Le Lézard
Classified in: Health
Subjects: PDT, SCZ

Centre for Aging + Brain Health Innovation accelerates development and testing of new Quebec-based healthcare innovations for older adults

MONTRÉAL, Aug. 13, 2019 /CNW/ - The Centre for Aging + Brain Health Innovation (CABHI), powered by Baycrest, in collaboration with four academic centres in Quebec, announced support for the validation testing of two new healthcare innovations for older adults, specifically for those living with dementia.

The innovations received support through CABHI's Quebec Researcher-Clinician Partnership Program (QRCP2), in partnership with four Quebec-based academic centres: the RUIS McGill Centre of Excellence on Longevity (CIUSSS West-Central Montreal), Institut universitaire de gériatrie de Montréal (CIUSSS du Centre-Sud de l'Île-de-Montréal), Centre de recherche sur le vieillissement (CIUSSS Estrie-CHUS), and Centre d'excellence sur le vieillissement (CIUSSS de la Capitale-Nationale).

QRCP2 supports teams of clinicians and researchers collaborating to refine, test, validate and disseminate innovations at an advanced stage of development. Funded projects evaluate the application and impact of the innovation in real-world seniors' care settings, going beyond lab tests and other tightly controlled test environments.

The supported innovations are:

"CABHI's programs and services empower innovators to venture beyond the lab and test their solutions in real-world settings," said Dr. Allison Sekuler, Managing Director for CABHI, Sandra A. Rotman Chair in Cognitive Neuroscience, and Vice-President of Research at Baycrest. "Through CABHI's strong network of provincial partnerships, we fund projects from coast to coast ? getting much-needed innovations into the hands of folks who require them across the country. We're looking forward to seeing these projects make a real difference in the lives of older adults, their families and their caregivers in Quebec."

"The partnership with CABHI and the four Quebec-based academic centres has helped to accelerate the pace of innovation in our province and beyond. Through the QRCP2, two teams of researchers and clinicians in Quebec are given an opportunity to test, validate and refine their innovations for the benefit of the aging population," said Dr. Olivier Beauchet, Director of the RUIS McGill Centre of Excellence on Longevity, Geriatrician at the Jewish General Hospital, Professor at McGill University and the Joseph Kaufmann Chair in Geriatric Medicine.

About the Centre for Aging + Brain Health Innovation (CABHI)

About the RUIS McGill Centre of Excellence on Longevity

About the Centre de Recherche de l'Institut universitaire de gériatrie de Montréal

About the Centre de recherche sur le vieillissement de Sherbrooke

About the Centre d'excellence sur le vieillissement de Québec

SOURCE Baycrest Centre for Geriatric Care

These press releases may also interest you

at 02:05
Agilent Technologies Inc. announced today that Professor Hualiang Jiang has received an Agilent Thought Leader Award. Professor Jiang directs the Shanghai Institute of Materia Medica at the Chinese Academy of Sciences and is a leading researcher in...

at 01:05
Novigenix SA, a leading Immuno-Transcriptomics company that develops and commercializes solutions for early cancer detection and precision medicine, today announced a collaboration agreement with BioLizard, an innovative bioinformatics company that...

at 01:05
Takeda Pharmaceutical Company Limited ("Takeda") (TOKYO:4502/NYSE:TAK) today announced that it has been named in the 2019 Dow Jones Sustainability World Index, achieving more than double the average overall industry score. In addition, Takeda was...

at 00:05
Last year, over 23,500 youth (age 10 to 24) were hospitalizedi for harm caused by substance use ? the equivalent of 65 hospitalizations each day. A new report from the Canadian Institute for Health Information (CIHI) shows that cannabis and alcohol...

at 00:01
An article recently published in Radiology highlights the groundbreaking use of a new imaging technology introduced by Seno Medical Instruments, Inc.® (Seno Medical) to diagnose breast cancer. The technology may offer physicians a new, non-invasive...

at 00:00
Attorney Corsello has been practicing personal injury litigation and criminal law for over 35 years. He received his JD degree from Suffolk University Law School and his BA degree from the University of Connecticut. He was admitted to the Connecticut...

News published on 13 august 2019 at 10:27 and distributed by: